OVID – ovid therapeutics inc. (US:NASDAQ)
Stock Stats
News
12/27
01:05 am
ovid
Medium
Ovid Therapeutics (NASDAQ:OVID) was upgraded by analysts at Wall Street
12/22
10:25 am
ovid
Low
Ovid Therapeutics (NASDAQ:OVID) is now covered by analysts at Lifesci Capital. They set an "outperform" rating and a $4.00 price target on the stock.
12/22
08:02 am
ovid
High
Ovid Therapeutics (NASDAQ:OVID) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $2.00 price target on the stock.
12/18
09:05 am
ovid
Low
Ovid Therapeutics Reports Phase 1 Results for the First-Ever Direct Activator of Potassium-Chloride Cotransporter 2 (KCC2), OV350 Intravenous (IV) [Yahoo! Finance]
12/18
08:00 am
ovid
High
Ovid Therapeutics Reports Phase 1 Results for the First-Ever Direct Activator of Potassium-Chloride Cotransporter 2 (KCC2), OV350 Intravenous (IV)
11/12/2025
07:00 am
ovid
-5.0%
MISS
8/13/2025
08:00 am
ovid
50.8%
BEAT
5/13/2025
08:00 am
ovid
-8.7%
IN-LINE
3/11/2025
08:00 am
ovid
-3.2%
BEAT
12/22
08:02 am
Reiterates
Buy
Buy
HC Wainwright
High
17.8%
12/12
05:52 am
Upgrades
Strong-Buy
Roth Capital
Low
-1.2%
12/12
05:52 am
Upgrades
Strong-Buy
Roth Capital
Low
-1.2%
12/11
07:55 am
Initiates
Buy
Roth Capital
Medium
4.4%
12/11
07:55 am
Initiates
Buy
Roth Capital
Medium
4.4%
12/23
06:03 am
ovid
Low
Form EFFECT Ovid Therapeutics Inc.
12/22
04:29 pm
ovid
Low
Form 424B3 Ovid Therapeutics Inc.
12/18
06:07 pm
ovid
Medium
Form SCHEDULE 13G Ovid Therapeutics Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
12/18
04:15 pm
ovid
Medium
Form 4 Ovid Therapeutics Inc. For: Dec 11 Filed by: LEVIN JEREMY M
12/18
04:06 pm
ovid
Medium
Form SCHEDULE 13G Ovid Therapeutics Inc. Filed by: Affinity Asset Advisors, LLC
Show more
Top News Gainers
9/24 Form 8-K Ovid Therapeutics Inc. For: Sep 23 25.5%
6/18 Form 8-K Ovid Therapeutics Inc. For: Jun 18 14.2%
11/29 RBC bullish on OVID's 2020 catalysts [Seeking Alpha] 10.4%
9/23 Form 8-K Ovid Therapeutics Inc. For: Sep 23 10.3%
8/17 Ovid Therapeutics Inc (NASDAQ: OVID) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $2.00 price target on the stock. 9.8%
7/1 Ovid Therapeutics Inc (NASDAQ: OVID) had its "buy" rating re-affirmed by analysts at Cowen Inc. 9.6%
7/18 Ovid Therapeutics Inc (NASDAQ: OVID) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. 9.4%
10/10 Form 4 Ovid Therapeutics Inc. For: Oct 08 Filed by: LEVIN JEREMY M 7.5%
11/15 Form 4 Ovid Therapeutics Inc. For: Nov 13 Filed by: Bernstein Karen 6.6%
12/20 Form 4 Ovid Therapeutics Inc. For: Dec 18 Filed by: Perone Thomas Michael 6.0%
Top News Decliners
3/12 Ovid Therapeutics Inc (NASDAQ: OVID) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -28.1%
10/3 Ovid Therapeutics Announces Proposed Concurrent Public Offerings of Common Stock and Preferred Stock -26.8%
3/11 Ovid Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results, Provides Corporate Update for 2020 -18.8%
3/6 Ovid Therapeutics Inc (NASDAQ: OVID) had its "buy" rating re-affirmed by analysts at LADENBURG THALM/SH SH. They now have a $20.00 price target on the stock. -13.4%
5/7 Q1/2019 3/31/2019 EPS -0.460 ZacksConsensus N/A ActVsEst N/A - N/A -11.3%
6/27 Form 8-K Ovid Therapeutics Inc. For: Jun 27 -7.5%
9/26 Ovid Therapeutics Inc (NASDAQ: OVID) was given a new $14.00 price target on by analysts at Piper Jaffray Companies. They now have a "buy" rating on the stock. -6.9%
2/14 Form SC 13G/A Ovid Therapeutics Inc. Filed by: LEVIN JEREMY M -6.8%
11/4 Form 4 Ovid Therapeutics Inc. For: Nov 01 Filed by: Daly Timothy -5.9%
8/22 Ovid Therapeutics Inc (NASDAQ: OVID) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -5.6%
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.
Click Here To Register For The Live Online Workshop
In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

20715 N Pima Rd #F108
Scottsdale, AZ 85255
Email: info@newsquantified.com
Copyright Ⓒ News Quanitifed LLC. 1.1.3